This enduring material was recorded from a virtual (live) summit offered by the American Society for Clinical Pathology (ASCP) and the Association of Community Cancer Centers (ACCC) to help members of the cancer care team enhance their coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.
Hear considerations for treating patients with CLL during the pandemic, including best options, treatment timing, changes to the usual regimen, and how to prepare for the future.
The pandemic has heightened the distress patients with CLL face and taken its toll on providers. Learn strategies and solutions to these challenges and the path forward for providing patient care.
Panelists discussed considerations for resuming pre-pandemic level visits and procedures for patients with CLL, AML, and Multiple Myeloma. Hear wins and challenges in providing care in a pandemic.
Hear vaccine guidance for patients with cancer and National Comprehensive Cancer Network guidelines for COVID-19 vaccines, in addition to new treatment and prevention options.